Search Results

CosmosID, a renowned microbiome analytics company, is thrilled to announce a groundbreaking collaboration with Resilient Biotics, a leading microbiome platform company with a pipeline of products for maintaining respiratory tract health.

CosmosID® today announced a partnership for long-term support for Locus’ clinical trial initiatives.

A complete analysis of the microbiome should combine taxonomic profiling (“who is there?”) with functional characterization (“what are they doing?”) to discover the capabilities of an entire community of microorganisms.

General Automation Lab Technologies (GALT) and CosmosID today announced the launch of a new scientific challenge program to award a complete microbiome characterization workflow to one project addressing the role of the microbiome in human disease

ProDigest and CosmosID today announced the launch of a new scientific challenge programme where the winning abstract submission will win a pre-clinical gastrointestinal study with a comprehensive, end-to-end microbiome characterisation workflow.

General Automation Lab Technologies (GALT) and CosmosID today announced the launch of a new scientific challenge program to award a complete microbiome characterization workflow to one entrant.

CosmosID Inc., a leading microbial genomics company focused on standardized, high-resolution microbiome analysis, and Biomeostasis, SAS , a leading pre-clinical CRO that offers in vivo research services in the fields of metabolic & GI diseases, today announced a strategic partnership to provide standa

In early 2020 when the US Food and Drug Administration (FDA) issued a series of safety alerts on the risk of transmitting SARS-CoV-2 via fecal microbiota transplantation (FMT), the Cambridge-based stool bank OpenBiome was left with freezers full of processed donor stool samples that could not be released until tested for the new virus.

Zymo Research and CosmosID announce their partnership to provide microbiome researchers with an integrated end to end solution for accurate microbiome analysis.